
=== FINAL SUMMARY ===

Over the fiscal years ending March 31, 2017, 2018, and 2019, the company experienced a shift in its cost structure, with notable changes in various expense categories.

1. **Cost of Revenues**: There was a consistent decrease in the cost of revenues, dropping from $282 in 2017 to $234 in 2019, indicating improved efficiency or cost management in this area.

2. **Research and Development**: Investment in research and development increased significantly, from $980 in 2017 to $1310 in 2019, reflecting a strategic focus on innovation and product development.

3. **Overall Expenses**: Total costs rose each year, from $1877 in 2017 to $2266 in 2019, driven by increases in research and development and selling, general, and administrative expenses.

4. **Expense Ratios**: The proportion of research and development costs relative to total costs grew from 52.2% in 2017 to 57.8% in 2019, while the cost of revenues as a percentage of total costs decreased from 15.0% to 10.3%, highlighting a shift towards prioritizing R&D.

Answer Echoes:
- [TREND] Cost of revenues decreased consistently: $282 (2017) → $259 (2018) → $234 (2019)
- [TREND] Research and development costs increased: $980 (2017) → $1,141 (2018) → $1,310 (2019)
- [TREND] Selling, general and administrative expenses rose: $615 (2017) → $670 (2018) → $722 (2019)
- [TREND] Total costs increased each year: $1,877 (2017) → $2,070 (2018) → $2,266 (2019)
- [RATIO] Research and development as a percentage of total costs increased: 52.2% (2017) → 55.1% (2018) → 57.8% (2019)
- [RATIO] Cost of revenues as a percentage of total costs decreased: 15.0% (2017) → 12.5% (2018) → 10.3% (2019)
- [SCOPE] Covers fiscal years ending March 31, 2019, 2018, and 2017.
- [DEFINITION] "Stock-based compensation expense" includes Employee Stock Purchase Plan costs.
- [SOURCE] Total expenses: $2.3M (2019), $2.1M (2018), $1.9M (2017).
- [NOTE] Employee Stock Purchase Plan costs: $211K (2019), $207K (2018), $150K (2017).
- [WARNING] Ensure allocation of expenses aligns with fiscal year-end dates.

=== LOGS (per-agent) ===
{'TabuSynth': {'cot': 'The financial table provides data on costs over three '
                      'years, allowing for analysis of trends, ratios, '
                      'anomalies, and outliers.',
               'result': '- [TREND] Cost of revenues decreased consistently: '
                         '$282 (2017) → $259 (2018) → $234 (2019)\n'
                         '- [TREND] Research and development costs increased: '
                         '$980 (2017) → $1,141 (2018) → $1,310 (2019)\n'
                         '- [TREND] Selling, general and administrative '
                         'expenses rose: $615 (2017) → $670 (2018) → $722 '
                         '(2019)\n'
                         '- [TREND] Total costs increased each year: $1,877 '
                         '(2017) → $2,070 (2018) → $2,266 (2019)\n'
                         '- [RATIO] Research and development as a percentage '
                         'of total costs increased: 52.2% (2017) → 55.1% '
                         '(2018) → 57.8% (2019)\n'
                         '- [RATIO] Cost of revenues as a percentage of total '
                         'costs decreased: 15.0% (2017) → 12.5% (2018) → 10.3% '
                         '(2019)',
               'raw': '{ "reasoning": "The financial table provides data on '
                      'costs over three years, allowing for analysis of '
                      'trends, ratios, anomalies, and outliers.", "bullets": '
                      '["- [TREND] Cost of revenues decreased consistently: '
                      '$282 (2017) → $259 (2018) → $234 (2019)", "- [TREND] '
                      'Research and development costs increased: $980 (2017) → '
                      '$1,141 (2018) → $1,310 (2019)", "- [TREND] Selling, '
                      'general and administrative expenses rose: $615 (2017) → '
                      '$670 (2018) → $722 (2019)", "- [TREND] Total costs '
                      'increased each year: $1,877 (2017) → $2,070 (2018) → '
                      '$2,266 (2019)", "- [RATIO] Research and development as '
                      'a percentage of total costs increased: 52.2% (2017) → '
                      '55.1% (2018) → 57.8% (2019)", "- [RATIO] Cost of '
                      'revenues as a percentage of total costs decreased: '
                      '15.0% (2017) → 12.5% (2018) → 10.3% (2019)"] }'},
 'Contextron': {'cot': 'The context provides specific details about '
                       'stock-based compensation expenses recognized by the '
                       'company over three fiscal years. This information is '
                       'crucial for accurately interpreting related figures in '
                       'a financial table, ensuring that the expenses are '
                       'correctly attributed to the appropriate fiscal years '
                       'and components, such as the Employee Stock Purchase '
                       'Plan.',
                'result': '- [SCOPE] Covers fiscal years ending March 31, '
                          '2019, 2018, and 2017.\n'
                          '- [DEFINITION] "Stock-based compensation expense" '
                          'includes Employee Stock Purchase Plan costs.\n'
                          '- [SOURCE] Total expenses: $2.3M (2019), $2.1M '
                          '(2018), $1.9M (2017).\n'
                          '- [NOTE] Employee Stock Purchase Plan costs: $211K '
                          '(2019), $207K (2018), $150K (2017).\n'
                          '- [WARNING] Ensure allocation of expenses aligns '
                          'with fiscal year-end dates.',
                'raw': 'The context provides specific details about '
                       'stock-based compensation expenses recognized by the '
                       'company over three fiscal years. This information is '
                       'crucial for accurately interpreting related figures in '
                       'a financial table, ensuring that the expenses are '
                       'correctly attributed to the appropriate fiscal years '
                       'and components, such as the Employee Stock Purchase '
                       'Plan.\n'
                       '\n'
                       '- [SCOPE] Covers fiscal years ending March 31, 2019, '
                       '2018, and 2017.\n'
                       '- [DEFINITION] "Stock-based compensation expense" '
                       'includes Employee Stock Purchase Plan costs.\n'
                       '- [SOURCE] Total expenses: $2.3M (2019), $2.1M (2018), '
                       '$1.9M (2017).\n'
                       '- [NOTE] Employee Stock Purchase Plan costs: $211K '
                       '(2019), $207K (2018), $150K (2017).\n'
                       '- [WARNING] Ensure allocation of expenses aligns with '
                       'fiscal year-end dates.'},
 'SummaCraft': {'cot': '(omitted)',
                'result': 'Over the fiscal years ending March 31, 2017, 2018, '
                          'and 2019, the company experienced a shift in its '
                          'cost structure, with notable changes in various '
                          'expense categories.\n'
                          '\n'
                          '1. **Cost of Revenues**: There was a consistent '
                          'decrease in the cost of revenues, dropping from '
                          '$282 in 2017 to $234 in 2019, indicating improved '
                          'efficiency or cost management in this area.\n'
                          '\n'
                          '2. **Research and Development**: Investment in '
                          'research and development increased significantly, '
                          'from $980 in 2017 to $1310 in 2019, reflecting a '
                          'strategic focus on innovation and product '
                          'development.\n'
                          '\n'
                          '3. **Overall Expenses**: Total costs rose each '
                          'year, from $1877 in 2017 to $2266 in 2019, driven '
                          'by increases in research and development and '
                          'selling, general, and administrative expenses.\n'
                          '\n'
                          '4. **Expense Ratios**: The proportion of research '
                          'and development costs relative to total costs grew '
                          'from 52.2% in 2017 to 57.8% in 2019, while the cost '
                          'of revenues as a percentage of total costs '
                          'decreased from 15.0% to 10.3%, highlighting a shift '
                          'towards prioritizing R&D.\n'
                          '\n'
                          'Answer Echoes:\n'
                          '- [TREND] Cost of revenues decreased consistently: '
                          '$282 (2017) → $259 (2018) → $234 (2019)\n'
                          '- [TREND] Research and development costs increased: '
                          '$980 (2017) → $1,141 (2018) → $1,310 (2019)\n'
                          '- [TREND] Selling, general and administrative '
                          'expenses rose: $615 (2017) → $670 (2018) → $722 '
                          '(2019)\n'
                          '- [TREND] Total costs increased each year: $1,877 '
                          '(2017) → $2,070 (2018) → $2,266 (2019)\n'
                          '- [RATIO] Research and development as a percentage '
                          'of total costs increased: 52.2% (2017) → 55.1% '
                          '(2018) → 57.8% (2019)\n'
                          '- [RATIO] Cost of revenues as a percentage of total '
                          'costs decreased: 15.0% (2017) → 12.5% (2018) → '
                          '10.3% (2019)\n'
                          '- [SCOPE] Covers fiscal years ending March 31, '
                          '2019, 2018, and 2017.\n'
                          '- [DEFINITION] "Stock-based compensation expense" '
                          'includes Employee Stock Purchase Plan costs.\n'
                          '- [SOURCE] Total expenses: $2.3M (2019), $2.1M '
                          '(2018), $1.9M (2017).\n'
                          '- [NOTE] Employee Stock Purchase Plan costs: $211K '
                          '(2019), $207K (2018), $150K (2017).\n'
                          '- [WARNING] Ensure allocation of expenses aligns '
                          'with fiscal year-end dates.',
                'raw': 'Over the fiscal years ending March 31, 2017, 2018, and '
                       '2019, the company experienced a shift in its cost '
                       'structure, with notable changes in various expense '
                       'categories.\n'
                       '\n'
                       '1. **Cost of Revenues**: There was a consistent '
                       'decrease in the cost of revenues, dropping from $282 '
                       'in 2017 to $234 in 2019, indicating improved '
                       'efficiency or cost management in this area.\n'
                       '\n'
                       '2. **Research and Development**: Investment in '
                       'research and development increased significantly, from '
                       '$980 in 2017 to $1,310 in 2019, reflecting a strategic '
                       'focus on innovation and product development.\n'
                       '\n'
                       '3. **Overall Expenses**: Total costs rose each year, '
                       'from $1,877 in 2017 to $2,266 in 2019, driven by '
                       'increases in research and development and selling, '
                       'general, and administrative expenses.\n'
                       '\n'
                       '4. **Expense Ratios**: The proportion of research and '
                       'development costs relative to total costs grew from '
                       '52.2% in 2017 to 57.8% in 2019, while the cost of '
                       'revenues as a percentage of total costs decreased from '
                       '15.0% to 10.3%, highlighting a shift towards '
                       'prioritizing R&D.'}}
